× Industry Reports Services Press Release Contact us About us

Europe Animal Model Market Forecast 2027 By Application (Research & Development {Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Obesity, NAFLD/NASH, Renal Disease, Diabetic Eye Disease, Fibrosis, Microbiome}, Production and Quality Control, Academics, Preclinical Applications {Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Obesity, NAFLD/NASH, Renal Disease, Diabetic Eye Disease, Fibrosis, Microbiome}), By Animal Type (Mice, Rats, Fish, Birds, Cattles, Pigs, Amphibians, Guinea Pigs, Dogs, Cats, Rabbits, Monkeys, Sheep, Hamsters), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-government}, Academic and Research Institutes, Contract Research Organizations (CRO)), Research Report, Regional Outlook (Germany, UK, France, Spain, Italy, Switzerland, Netherlands, Czech Republic, Poland, Belgium, Finland, Hungary, Denmark, Ireland, Sweden), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
Published Date: June 2021 | Publisher: Graphical Research Report ID: GR1853 | Delivery : PDF  Request Free Sample

Report Content

Chapter 1   Methodology

1.1    Methodology

1.2    Market definition

1.3    Animal model market forecast parameters

1.4    Data sources

1.4.1    Secondary

1.4.1.1    Paid sources

1.4.1.2    Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    Europe animal model industry 3600 synopsis, 2016 - 2027

2.1.1    Country trends

2.1.2    Animal type trends

2.1.3    Technology trends

2.1.4    Application trends

2.1.5    Use trends

2.1.6    End-use trends

Chapter 3   Europe Animal Model Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 - 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Growing number of pharmaceutical research and development activities

3.3.1.2    Large number of applications in healthcare domain

3.3.1.3    Physiological similarities between human and animal

3.3.1.4    Emergence of CRISPR as a powerful tool in the field of biomedical research

3.3.1.5    Growing consumption of personalized medicine driving the demand for humanized mice models

3.3.2    Industry pitfalls & challenges

3.3.2.1    Expensive process

3.3.2.2    Strict regulations and guidelines

3.3.2.3    Growing opposition on animal testing by several organizations

3.4    Analysis of COVID-19 impact on the industry

3.5    Porter’s analysis

3.6    Competitive landscape, 2020

3.7    PEST analysis

Chapter 4   Europe Animal model Market, By Animal Type

4.1    Market trends

4.2    Mice

4.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.2.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.3    Rats

4.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.3.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.4    Fish

4.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.4.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.5    Birds

4.5.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.5.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.6    Cattles

4.6.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.6.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.7    Pigs

4.7.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.7.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.8    Amphibians

4.8.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.8.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.9    Guinea Pigs

4.9.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.9.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.10    Dogs

4.10.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.10.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.11    Cats

4.11.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.11.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.12    Rabbits

4.12.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.12.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.13    Monkeys

4.13.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.13.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.14    Sheep

4.14.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.14.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.15    Hamsters

4.15.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.15.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

4.16    Others

4.16.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.16.2    Market estimates and forecast, by country, 2016 – 2027 (Units)

Chapter 5   Europe Animal Model Market, By Technology

5.1    Market trends

5.2    CRISPR

5.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

5.3    Microinjection

5.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

5.4    Embryonic Stem Cell Injection

5.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

5.5    Nuclear Transfer

5.5.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

5.6    Others

5.6.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

Chapter 6   Europe Animal Model Market, By Application

6.1    Market trends

6.2    Research & Development

6.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.2    Infectious Disease

6.2.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.3    Immunological Disease

6.2.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.4    Cancer

6.2.4.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.5    Cardiovascular Disease

6.2.5.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.6    Diabetes

6.2.6.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.7    Genetic Disease

6.2.7.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.8    Neurological Disease

6.2.8.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.9    Obesity

6.2.9.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.10    NAFLD/NASH

6.2.10.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.11    Renal Disease

6.2.11.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.12    Diabetic Eye Disease

6.2.12.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.13    Fibrosis

6.2.13.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.14    Microbiome

6.2.14.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.2.15    Others

6.2.15.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.3    Production & Quality Control

6.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.4    Academics

6.4.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5    Preclinical Applications

6.5.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.2    Infectious Disease

6.5.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.3    Immunological Disease

6.5.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.4    Cancer

6.5.4.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.5    Cardiovascular Disease

6.5.5.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.6    Diabetes

6.5.6.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.7    Genetic Disease

6.5.7.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.8    Neurological Disease

6.5.8.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.9    Obesity

6.5.9.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.10    NAFLD/NASH

6.5.10.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.11    Renal Disease

6.5.11.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.12    Diabetic Eye Disease

6.5.12.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.13    Fibrosis

6.5.13.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.14    Microbiome

6.5.14.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5.15    Others

6.5.15.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.6    Others

6.6.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

Chapter 7   Europe Animal Model Market, By Use

7.1    Market trends

7.2    Human

7.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

7.3    Veterinary

7.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

Chapter 8   Europe Animal Model Market, By End-use

8.1    Market trends

8.2    Companies

8.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

8.2.2    Pharmaceutical

8.2.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

8.2.3    Biotechnology

8.2.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

8.2.4    Cosmetics

8.2.4.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

8.2.5    Others

8.2.5.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

8.3    Organizations

8.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

8.3.2    Government

8.3.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

8.3.3    Non-government

8.3.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

8.4    Academic & Research Institutes

8.4.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

8.5    Contract Research Organizations

8.5.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

Chapter 9   Europe Animal Model Market, By Country

9.1    Market trends

9.2    Germany

9.2.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.2.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.2.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.2.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.2.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.2.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.2.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.2.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.2.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.2.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.3    UK

9.3.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.3.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.3.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.3.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.3.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.3.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.3.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.3.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.3.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.3.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.4    France

9.4.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.4.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.4.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.4.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.4.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.4.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.4.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.4.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.4.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.4.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.5    Spain

9.5.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.5.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.5.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.5.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.5.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.5.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.5.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.5.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.5.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.5.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.6    Italy

9.6.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.6.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.6.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.6.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.6.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.6.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.6.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.6.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.6.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.6.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.7    Switzerland

9.7.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.7.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.7.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.7.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.7.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.7.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.7.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.7.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.7.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.7.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.8    Netherlands

9.8.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.8.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.8.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.8.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.8.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.8.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.8.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.8.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.8.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.8.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.9    Czech Republic

9.9.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.9.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.9.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.9.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.9.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.9.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.9.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.9.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.9.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.9.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.10    Poland

9.10.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.10.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.10.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.10.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.10.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.10.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.10.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.10.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.10.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.10.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.11    Belgium

9.11.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.11.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.11.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.11.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.11.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.11.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.11.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.11.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.11.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.11.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.12    Finland

9.12.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.12.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.12.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.12.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.12.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.12.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.12.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.12.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.12.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.12.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.13    Hungary

9.13.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.13.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.13.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.13.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.13.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.13.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.13.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.13.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.13.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.13.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.14    Denmark

9.14.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.14.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.14.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.14.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.14.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.14.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.14.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.14.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.14.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.14.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.15    Ireland

9.15.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.15.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.15.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.15.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.15.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.15.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.15.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.15.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.15.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.15.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.16    Sweden

9.16.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.16.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.16.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.16.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.16.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.16.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.16.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.16.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.16.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.16.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

Chapter 10   Company Profiles

10.1    Charles River

10.1.1    Business overview

10.1.2    Financial data

10.1.3    Product landscape

10.1.4    Strategic outlook

10.2    Envigo

10.2.1    Business overview

10.2.2    Financial data

10.2.3    Product landscape

10.2.4    Strategic outlook

10.3    genOway

10.3.1    Business overview

10.3.2    Financial data

10.3.3    Product landscape

10.3.4    Strategic outlook

10.4    PharmaLegacy

10.4.1    Business overview

10.4.2    Financial data

10.4.3    Product landscape

10.4.4    Strategic outlook

10.5    Taconic Biosciences

10.5.1    Business overview

10.5.2    Financial data

10.5.3    Product landscape

10.5.4    Strategic outlook

10.6    Janvier Labs

10.6.1    Business overview

10.6.2    Financial data

10.6.3    Product landscape

10.6.4    Strategic outlook

10.7    The Jackson Laboratory

10.7.1    Business overview

10.7.2    Financial data

10.7.3    Product landscape

10.7.4    Strategic outlook

10.8    Crown Bioscience Inc.

10.8.1    Business overview

10.8.2    Financial data

10.8.3    Product landscape

10.8.4    Strategic outlook

10.9    Harbor Antibodies BV

10.9.1    Business overview

10.9.2    Financial data

10.9.3    Product landscape

10.9.4    Strategic outlook
 


Premium Report

Have questions?
  • Inquire Before Buying
  • Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

     1-800-986-6917

     [email protected]